Korea's second-generation CEOs urged to create new management philosophy environments

Published: 2004-03-12 06:59:00

Updated: 2004-03-12 06:59:00

In the domestic pharmaceutical sector where a great number of drug makers are struggling with less profitability amid protracted business slump, there are widespread voices that unlike the predecessors preoccupied with their company growth in the past, Korea's second or third CEOs boasting of the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK